Peter Wells
Directeur/Membre du Conseil chez Novavax AB
Profil
Peter Wells is currently a Director at Novavax AB and a Director at Global Alliance for Livestock Veterinary Medicines.
He previously worked as a Director at The Moredun Foundation, Jenner Vaccine Foundation, and Elanco Tiergesundheit AG.
Dr. Wells holds a doctorate degree from The University of Nottingham.
Postes actifs de Peter Wells
| Sociétés | Poste | Début |
|---|---|---|
Novavax AB
 Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Directeur/Membre du Conseil | 04/08/2009 |
Global Alliance for Livestock Veterinary Medicines
 Global Alliance for Livestock Veterinary Medicines Miscellaneous Commercial ServicesCommercial Services The Global Alliance for Livestock Veterinary Medicines provides social services. The CEO of the British company is Peter Jeffries. | Directeur/Membre du Conseil | - |
Anciens postes connus de Peter Wells
| Sociétés | Poste | Fin |
|---|---|---|
Elanco Tiergesundheit AG
 Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Directeur Technique/Scientifique/R&D | - |
| The Moredun Foundation | Directeur/Membre du Conseil | - |
| Jenner Vaccine Foundation | Directeur/Membre du Conseil | - |
Formation de Peter Wells
| The University of Nottingham | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Elanco Tiergesundheit AG
Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Health Technology |
Novavax AB
Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Health Technology |
| The Moredun Foundation | Miscellaneous |
| Jenner Vaccine Foundation | |
Global Alliance for Livestock Veterinary Medicines
Global Alliance for Livestock Veterinary Medicines Miscellaneous Commercial ServicesCommercial Services The Global Alliance for Livestock Veterinary Medicines provides social services. The CEO of the British company is Peter Jeffries. | Commercial Services |
